Stockscreener 앱 받기
105.26
0.73%
0.76
Boston Scientific Corp 주식(BSX)의 최신 뉴스
Boston Scientific’s longtime DEI, HR leader exits for chief HR role at new company - MassDevice
Insider Sell: Edward Ludwig Sells 4,000 Shares of Boston Scientific Corp (BSX) - GuruFocus
Piper Sandler maintains Boston Scientific stock at Overweight - Investing.com
Continence Care Market Size to Surpass USD 9.54 Billion by 2031 With 5.6% CAGR, Surging Prevalence of Chronic Diseases Propels the Demand | The Insight Partners - GlobeNewswire Inc.
Boston Scientific (BSX) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance
Boston Scientific (NYSE:BSX) Receives “Buy” Rating from Needham & Company LLC - Defense World
Boston Scientific Scraps This Aortic Valve, Sticks To 2025 Outlook - Benzinga
Boston Scientific (BSX) Ends Acurate TAVR Program, Shifts Focus to Promising Projects | BSX Stock News - GuruFocus
BSX: Analyst Reiterates Buy Rating for Boston Scientific | BSX Stock News - GuruFocus
In TAVR setback, Boston Sci pulls plug on Acurate valves - BioWorld MedTech
Boston Scientific discontinues Acurate TAVR sales, cites regulatory burden - MassDevice
Boston Scientific Ends ACURATE Valve Sales By Investing.com - Investing.com Canada
Evercore ISI maintains Boston Scientific stock at Outperform - Investing.com
TD Cowen maintains Boston Scientific stock at $115 target By Investing.com - Investing.com South Africa
TD Cowen maintains Boston Scientific stock at $115 target - Investing.com
Boston Scientific (BSX) Discontinues Sales of ACURATE Aortic Valve Systems - GuruFocus
Boston Scientific (BSX) Discontinues Valve Product Amid Regulato - GuruFocus
JPMorgan maintains Boston Scientific stock with $135 target - Investing.com
Boston Scientific ends TAVR sales; J&J shares Monarch robot data - Yahoo Finance
Citi maintains Buy on Boston Scientific, keeps $125 target - Investing.com
Needham sees Boston Scientific stock as a buy, target at $115 - Investing.com
Boston Scientific (BSX) Halts Aortic Valve Systems, Boosting Com - GuruFocus
Boston Scientific (BSX) Halts Global Sales of ACURATE Valve Syst - GuruFocus
Boston Scientific at Bernstein Conference: Strategic Growth and Innovation - Investing.com
Abercrombie & Fitch, Boston Scientific, DoorDash - TradingView
Boston Scientific (BSX) Halts Global Sales of ACURATE Valve Systems | BSX Stock News - GuruFocus
Boston Scientific Ends ACURATE Valve Sales - Investing.com
Boston Scientific shares drop as valve systems are discontinued - Investing.com
Boston Scientific (NYSE:BSX) Q1 Earnings: Leading The Medical Devices & SuppliesDiversified Pack - Yahoo Finance
Boston Scientific (BSX) Up 3.3% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Boston Scientific (BSX) Price Target Raised by Citigroup | BSX S - GuruFocus
India Catheters Market Set to Witness Significant Growth - openPR.com
Was Jim Cramer Right About Boston Scientific Corporation (BSX)? - Insider Monkey
Endoscopy Devices Global Market Overview 2021-2030 with Forecasts 2024-2030 - GlobeNewswire Inc.
Boston Scientific Acurate neo2 fails to meet non-inferiority in study - MassDevice
July 3rd Options Now Available For Boston Scientific (BSX) - Nasdaq
Investors in Boston Scientific (NYSE:BSX) have seen splendid returns of 182% over the past five years - Yahoo Finance
Boston Scientific (BSX) Target Price Increased by Citi Analyst | - GuruFocus
Boston Scientific (BSX) Target Price Increased by Citi Analyst | BSX Stock News - GuruFocus
Boston Scientific has positive real-world Acurate Prime TAVI data - MassDevice
Here's How Much You'd Have If You Invested $1000 in Boston Scientific a Decade Ago - Yahoo Finance
$1000 Invested In Boston Scientific 15 Years Ago Would Be Worth This Much TodayBoston Scientific (NYSE:BSX) - Benzinga
Boston Scientific’s rating upgraded to A3 by Moody’s Ratings - Investing.com
Market shift: Boston Scientific emerges as Massachusetts' most valuable public company - The Business Journals
Boston Sci Closes Division Sale to Stryker Corp. On Jan. 3, Boston Scientific Corp. completed the - Medical Product Outsourcing
Boston Scientific Adds Seat to Board - Medical Product Outsourcing
Boston Scientific and Other Firms Gain Favorable Ruling in Patent Infringement Case - Medical Product Outsourcing
Boston Scientific Loses Federal Case Over Vaginal Mesh Product - Medical Product Outsourcing
Boston Scientific (NYSE:BSX) Ticks All The Boxes When It Comes To Earnings Growth - Yahoo Finance
Boston Scientific Expands Board with Two New Members - Medical Product Outsourcing
Boston Scientific Posts First-Quarter Profit - Medical Product Outsourcing
Boston Scientific Stents Get FDA Nod for Heart Attack Patients - Medical Product Outsourcing
Forecasting The Future: 9 Analyst Projections For Boston Scientific - Benzinga
Boston Scientific (BSX) Price Target Raised by Morgan Stanley | BSX Stock News - GuruFocus
Colonoscopes Market Report 2025: Valued at $2.5 Billion and Projected to Reach $3.4 Billion by 2030 - GlobeNewswire Inc.
Boston Scientific Launches Next Generation of Cardiac Mapping for the FARAPULSE™ Pulsed Field Ablation System - Quantisnow
Boston Scientific Exec Joins Arsenal Medical’s Board - Medical Product Outsourcing
Ureteral Stents Market Detailed In New Research Report 2025 | - openPR.com
Is it Worth Retaining Boston Scientific Stock in Your Portfolio Now? - Yahoo Finance
Boston Scientific at Bank of America Conference: Strategic Growth Insights - Investing.com
Boston Scientific To Present At Bank Of America's Health Care Conference; Webcast At 11:00 AM ET - Nasdaq
Product liability lawsuits target Medtronic, Boston Scientific spinal cord stim tech - MassDevice
Electroceuticals Market Top PlayersMedtronic Plc (Ireland), - openPR.com
0.08%
자본화:
|
볼륨(24시간):